Insiders · Profile

Touchon Pascal

President and CEO at Atara Biotherapeutics. Filing since 18 May 2020. CIK 0001780060

Company
Date
Role
Action
Shares
Amount
Of holding
16 Aug 2024
President and CEO
Sold at will
3,038
$20.14K
4.2%
16 May 2024
President and CEO
Sold at will
81,506
$50.29K
4.3%
4 Mar 2024
President and CEO
Sold at will
24,844
$17.89K
1.3%
16 Nov 2023
President and CEO
Sold at will
20,409
$7.94K
3.0%
16 Aug 2023
President and CEO
Sold at will
30,766
$50.83K
4.4%
27 Jun 2023
President and CEO
Sold at will
14,291
$23.72K
2.0%
16 May 2023
President and CEO
Sold at will
29,766
$60.63K
4.0%
2 Mar 2023
President and CEO
Sold, plan not stated
15,679
$56.87K
2.0%
16 Nov 2022
President and CEO
Sold, plan not stated
15,591
$70.00K
3.4%
16 Aug 2022
President and CEO
Sold, plan not stated
14,806
$74.55K
3.1%
27 Jun 2022
President and CEO
Sold, plan not stated
14,220
$102.38K
2.9%
17 May 2022
President and CEO
Sold, plan not stated
13,913
$73.96K
2.8%
1 Mar 2022
President and CEO
Sold, plan not stated
8,828
$87.01K
1.7%
16 Nov 2021
President and CEO
Sold, plan not stated
8,402
$143.82K
2.5%
17 Aug 2021
President and CEO
Sold, plan not stated
8,223
$103.05K
2.4%
25 Jun 2021
President and CEO
Sold, plan not stated
14,194
$231.66K
4.0%
18 May 2021
President and CEO
Sold, plan not stated
8,313
$120.95K
2.3%
2 Mar 2021
President and CEO
Sold, plan not stated
4,887
$81.81K
1.3%
17 Nov 2020
President and CEO
Sold, plan not stated
4,716
$93.25K
1.8%
18 Aug 2020
President and CEO
Sold, plan not stated
4,807
$58.12K
1.8%
25 Jun 2020
President and CEO
Sold, plan not stated
12,135
$156.78K
4.4%
18 May 2020
President and CEO
Sold, plan not stated
3,195
$35.85K
1.1%
22 decisions on file.